论文信息 - A Phase I/II Study of AZD2811 Nanoparticles (NP) As Monotherapy or in Combination in Treatment-Naïve or Relapsed/Refractory AML/MDS Patients Not Eligible for Intensive Induction Therapy - 字舞流文

A Phase I/II Study of AZD2811 Nanoparticles (NP) As Monotherapy or in Combination in Treatment-Naïve or Relapsed/Refractory AML/MDS Patients Not Eligible for Intensive Induction Therapy

Suzanne F. Jones | G. Fabbri | G. Borthakur | J. E. Pease | A. Asch | C. Adelman | D. Strickland | P. Overend | E. Sainsbury | W. Donnellan | E. Atallah | J. Cosaert | M. Patel | Jay Yang | J. Charlton | Alexander MacDonald | Simon A. Smith | J. Travers | A. Eghtedar | Anna Korzeniowska